AEON Biopharma Inc.

AEON | AMEX

Price Alert Chart Builder DCF Calculator

$0.48

-$0.02 (-4.52%)

Jul 10, 2026, 3:58 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	3.01M	13K	5.16M	9.75M	5.13M	20.17M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	948K	29K	29K	34K	360K	838K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	392K	1.58M	1.06M	92K	26K	n/a
Total Current Assets	3.4M	1.59M	6.22M	9.84M	5.15M	20.38M
Property-Plant & Equipment	1.21M	1.52M	594K	906K	922K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.16M	1.55M	623K	940K	1.28M	838K
Total Assets	5.56M	3.14M	6.85M	10.78M	6.44M	21.21M
Account Payables	942K	5.91M	3.39M	7.81M	1.19M	2.03M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	70.87M	15.6M	n/a
Other Current Liabilities	2.87M	1.07M	943K	1.11M	1.07M	1.25M
Total Current Liabilities	6.9M	14.15M	13.05M	82.57M	20.8M	4.2M
Long-Term Debt	34.6M	11.69M	n/a	60.43M	70.76M	72.16M
Other Long-Term Liabilities	18.2M	4.73M	146.84M	137.95M	138.17M	148.09M
Total Long-Term Liabilities	53.69M	17.56M	146.84M	198.62M	209.46M	220.25M
Total Liabilities	60.59M	31.71M	159.89M	281.19M	230.26M	224.45M
Total Debt	35.75M	12.96M	278K	131.53M	86.89M	72.16M
Book Value	-55.03M	-28.57M	-153.04M	-270.41M	-223.82M	-203.23M
Book Value Per Share	-5.55	-49.60	-1.99	-140.22	-127.64	-2.22K
Common Stock	9K	4K	4K	14K	14K	11K
Retained Earnings	-470.82M	-431.6M	-473.6M	-474.84M	-422.28M	-366.65M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	-55.03M	-28.57M	-153.04M	-287.5M	-234.94M	-208.27M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a